Fingerprint
Dive into the research topics of 'Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia
John M.L. Ebos, Jennifer Tran, Zubin Master, Daniel Dumont, Junia V. Melo, Elisabeth Buchdunger, Robert S. Kerbel
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations